Nanomaterials have many opportunities for drug delivery, diagnostics, and therapeutic interventions. These materials, typically at the nanoscale (1-100 nanometers), exhibit unique physicochemical properties that distinguish them from bulk counterparts. In drug delivery, nanomaterials enable precise control over drug release kinetics, improving therapeutic efficacy while minimizing side effects. Lipid-based nanoparticles, polymeric nanocarriers, and metallic nanoparticles have all demonstrated promise in enhancing drug solubility, stability, and bioavailability.
Additionally, the targeted delivery of drugs to specific cells or tissues is facilitated by the ability of nanomaterials to passively accumulate at pathological sites through the enhanced permeability and retention effect. Furthermore, nanomaterials play a pivotal role in diagnostic imaging, allowing for highly sensitive and specific detection of diseases through contrast agents or nanoscale imaging probes. Despite the immense potential, the application of nanomaterials in the pharmaceutical field raises challenges related to safety, toxicity, and regulatory concerns, necessitating thorough research and development. As scientists continue to unravel the full potential of nanomaterials, their integration into pharmaceutical strategies holds promise for revolutionizing the way diseases are diagnosed and treated.
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Exploring classical ayurvedic drugs in hypertension
Prashant Bhokardankar, Datta Meghe Ayurved College, India
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : A unique role and and impact of catalytic antibodies (abzymes) in clinical practice: A novel strategy for predicting and preventing relapse in chronic autoimmune conditions
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : The promise of nanotechnology in personalized & precision medicine: Drug discovery & development being partnered with nanotechnologies via the revolution at the nanoscale
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : The promising future of the unique translational tool to manage beta-cell population renewal and regeneration to secure the post-diabetic period
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Easily injectable, organic solvent free self assembled hydrogel platform for endoscope mediated gastrointestinal polypectomy
Hitasha Vithalani , IIT Gandhinagar, India